CD8A and neoplasm: Pharmacological inhibition of macrophage lipid kinase, PI3kγ leads to reprogramming of TAMs to M1 resulting in restoration of CD8+ T cell mediated tumor suppression, reduced desmoplasia, metastasis and improved chemotherapeutic response [113].